Company intelligence / Profile preview

List Biological Laboratories

Campbell, California, United Stateslistlabs.com ↗

Ownership: Private
Development stage: Commercial

Overview

List Biological Laboratories manufactures and supplies bacterial toxins and related products for research use worldwide. The company has pioneered the production of clinical-grade lipopolysaccharide for trials and was among the first to manufacture live microbiome-based therapeutics for clinical studies. It also provides cGMP manufacturing services up to Phase II/III supply.

Therapeutic areas: Infectious Diseases
Modalities: Live biotherapeutic product therapyProteinRecombinant proteinToxoidAntibody
Industry: Contract Manufacturing Organization

Partnerships

Allergan (technology transfer of botulinum process in 2015)

Beyond the preview

Go deeper on List Biological Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on List Biological Laboratories.

Explore the full profile